Your browser doesn't support javascript.
loading
The selective 5-HT1A receptor agonist, NLX-112, exerts anti-dyskinetic effects in MPTP-treated macaques.
Depoortere, R; Johnston, T H; Fox, S H; Brotchie, J M; Newman-Tancredi, A.
Affiliation
  • Depoortere R; Neurolixis SAS, 81100, Castres, France.
  • Johnston TH; Atuka Inc, Toronto, ON, Canada; Krembil Research Institute, Toronto Western Hospital, University Health Network, Toronto, ON, Canada.
  • Fox SH; Movement Disorders Clinic, Toronto Western Hospital, University Health Network, Toronto, ON, Canada.
  • Brotchie JM; Atuka Inc, Toronto, ON, Canada; Krembil Research Institute, Toronto Western Hospital, University Health Network, Toronto, ON, Canada.
  • Newman-Tancredi A; Neurolixis SAS, 81100, Castres, France. Electronic address: anewmantancredi@neurolixis.com.
Parkinsonism Relat Disord ; 78: 151-157, 2020 09.
Article in En | MEDLINE | ID: mdl-32846366

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Piperidines / Pyridines / Dopamine Agents / Amantadine / Levodopa / Parkinsonian Disorders / Dyskinesia, Drug-Induced / Serotonin 5-HT1 Receptor Agonists Type of study: Etiology_studies / Prognostic_studies Limits: Animals Language: En Journal: Parkinsonism Relat Disord Journal subject: NEUROLOGIA Year: 2020 Document type: Article Affiliation country: Francia Country of publication: Reino Unido

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Piperidines / Pyridines / Dopamine Agents / Amantadine / Levodopa / Parkinsonian Disorders / Dyskinesia, Drug-Induced / Serotonin 5-HT1 Receptor Agonists Type of study: Etiology_studies / Prognostic_studies Limits: Animals Language: En Journal: Parkinsonism Relat Disord Journal subject: NEUROLOGIA Year: 2020 Document type: Article Affiliation country: Francia Country of publication: Reino Unido